Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle
- From the Centre for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Australia
- Address correspondence to Prof. Mark Hargreaves, School of Exercise and Nutrition Sciences, Deakin University, 221 Burwood Hwy., Burwood VIC 3125, Australia. E-mail: mharg{at}deakin.edu.au
Abstract
Overexpression of GLUT4 in skeletal muscle enhances whole-body insulin action. Exercise increases GLUT4 gene and protein expression, and a binding site for the myocyte enhancer factor 2 (MEF-2) is required on the GLUT4 promoter for this response. However, the molecular mechanisms involved remain elusive. In various cell systems, MEF-2 regulation is a balance between transcriptional repression by histone deacetylases (HDACs) and transcriptional activation by the nuclear factor of activated T-cells (NFAT), peroxisome proliferator-activated receptor-γ coactivator 1 (PGC-1), and the p38 mitogen-activated protein kinase. The purpose of this study was to determine if these same mechanisms regulate MEF-2 in contracting human skeletal muscle. Seven subjects performed 60 min of cycling at ∼70% of Vo2peak. After exercise, HDAC5 was dissociated from MEF-2 and exported from the nucleus, whereas nuclear PGC-1 was associated with MEF-2. Exercise increased total and nuclear p38 phosphorylation and association with MEF-2, without changes in total or nuclear p38 protein abundance. This result was associated with p38 sequence-specific phosphorylation of MEF-2 and an increase in GLUT4 mRNA. Finally, we found no role for NFAT in MEF-2 regulation. From these data, it appears that HDAC5, PGC-1, and p38 regulate MEF-2 and could be potential targets for modulating GLUT4 expression.
- AMPK, AMP kinase
- CaMK, calcium/calmodulin-dependent protein kinase
- HAT, histone acetyltransferase
- HDAC, histone deacetylase
- MAPK, mitogen-activated protein kinase
- MEF-2, myocyte enhancer factor 2
- MKK, MAPK kinase
- NFAT, nuclear factor of activated T-cells
- PGC-1, peroxisome proliferator-activated receptor-γ coactivator 1
Footnotes
-
- Accepted February 2, 2004.
- Received October 9, 2003.
- DIABETES











